Fintel reports that on November 5, 2025, Jefferies upgraded their outlook for Rigel Pharmaceuticals (NasdaqGS:RIGL) from Hold to Buy.
Analyst Price Forecast Suggests 3.30% Upside
As of October 30, 2025, the average one-year price target for Rigel Pharmaceuticals is $39.10/share. The forecasts range from a low of $23.23 to a high of $70.35. The average price target represents an increase of 3.30% from its latest reported closing price of $37.85 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Rigel Pharmaceuticals is 160MM, a decrease of 43.39%. The projected annual non-GAAP EPS is -0.21.
What is the Fund Sentiment?
There are 305 funds or institutions reporting positions in Rigel Pharmaceuticals. This is an increase of 22 owner(s) or 7.77% in the last quarter. Average portfolio weight of all funds dedicated to RIGL is 0.06%, an increase of 0.75%. Total shares owned by institutions increased in the last three months by 1.91% to 15,944K shares. 
The put/call ratio of RIGL is 0.26, indicating a bullish outlook.
What are Other Shareholders Doing?
Armistice Capital holds 1,600K shares representing 8.92% ownership of the company. In its prior filing, the firm reported owning 1,516K shares , representing an increase of 5.25%. The firm increased its portfolio allocation in RIGL by 26.51% over the last quarter.
Soleus Capital Management holds 658K shares representing 3.67% ownership of the company. In its prior filing, the firm reported owning 1,131K shares , representing a decrease of 71.80%. The firm decreased its portfolio allocation in RIGL by 44.26% over the last quarter.
Acadian Asset Management holds 623K shares representing 3.47% ownership of the company. In its prior filing, the firm reported owning 565K shares , representing an increase of 9.30%. The firm decreased its portfolio allocation in RIGL by 16.16% over the last quarter.
Capitolis Liquid Global Markets holds 592K shares representing 3.30% ownership of the company. In its prior filing, the firm reported owning 693K shares , representing a decrease of 17.17%. The firm decreased its portfolio allocation in RIGL by 26.34% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 549K shares representing 3.06% ownership of the company. No change in the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
